| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CBPA.2008.02.005 |
| P698 | PubMed publication ID | 18316043 |
| P2093 | author name string | Thomas Hesterkamp | |
| Mark Whittaker | |||
| P433 | issue | 3 | |
| P304 | page(s) | 260-268 | |
| P577 | publication date | 2008-03-19 | |
| P1433 | published in | Current Opinion in Chemical Biology | Q15758415 |
| P1476 | title | Fragment-based activity space: smaller is better | |
| P478 | volume | 12 |
| Q33952708 | A comparative study of fragment screening methods on the p38α kinase: new methods, new insights |
| Q33456643 | Advances in improving the quality and flexibility of compound management |
| Q35848043 | Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery |
| Q38910944 | Compound Design by Fragment-Linking |
| Q38890648 | Computational functional group mapping for drug discovery |
| Q33730340 | Design of Screening Collections for Successful Fragment-Based Lead Discovery |
| Q33417723 | Design of compound libraries for fragment screening |
| Q27675974 | Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening |
| Q27667921 | Differentiating analogous tRNA methyltransferases by fragments of the methyl donor |
| Q42954139 | Discovery of a Novel Hsp90 Inhibitor by Fragment Linking |
| Q26826945 | Fragment screening and HIV therapeutics |
| Q34392316 | Fragment screening of cyclin G-associated kinase by weak affinity chromatography |
| Q42882505 | Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12 |
| Q27654219 | Fragment-based identification of Hsp90 inhibitors |
| Q92443122 | Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead |
| Q24646409 | Identifying druggable disease-modifying gene products |
| Q26738768 | Process of Fragment-Based Lead Discovery-A Perspective from NMR |
| Q33469695 | The multiple roles of computational chemistry in fragment-based drug design |
| Q33838157 | The rise of fragment-based drug discovery |
| Q34626368 | Virtual screening of chemical libraries for drug discovery |
| Q49921691 | Whole cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular |
Search more.